Exposure-response analyses of liraglutide 3.0 mg for weight management.
about
Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial.Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic Analysis.Early Weight Loss with Liraglutide 3.0 mg Predicts 1-Year Weight Loss and is Associated with Improvements in Clinical Markers.Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.Effect of exenatide on postprandial glucose fluxes, lipolysis, and ß-cell function in non-diabetic, morbidly obese patients.Comparison of Efficacy and Safety of Liraglutide 3.0 mg in Individuals with BMI above and below 35 kg/m²: A Post-hoc Analysis.
P2860
Exposure-response analyses of liraglutide 3.0 mg for weight management.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Exposure-response analyses of liraglutide 3.0 mg for weight management.
@en
Exposure-response analyses of liraglutide 3.0 mg for weight management.
@nl
type
label
Exposure-response analyses of liraglutide 3.0 mg for weight management.
@en
Exposure-response analyses of liraglutide 3.0 mg for weight management.
@nl
prefLabel
Exposure-response analyses of liraglutide 3.0 mg for weight management.
@en
Exposure-response analyses of liraglutide 3.0 mg for weight management.
@nl
P2093
P2860
P356
P1476
Exposure-response analyses of liraglutide 3.0 mg for weight management
@en
P2093
C B Jensen
C W le Roux
L V Jacobsen
R V Overgaard
P2860
P304
P356
10.1111/DOM.12639
P50
P577
2016-03-01T00:00:00Z